Your browser doesn't support javascript.
loading
Genetic Mechanisms of Immune Evasion in Colorectal Cancer.
Grasso, Catherine S; Giannakis, Marios; Wells, Daniel K; Hamada, Tsuyoshi; Mu, Xinmeng Jasmine; Quist, Michael; Nowak, Jonathan A; Nishihara, Reiko; Qian, Zhi Rong; Inamura, Kentaro; Morikawa, Teppei; Nosho, Katsuhiko; Abril-Rodriguez, Gabriel; Connolly, Charles; Escuin-Ordinas, Helena; Geybels, Milan S; Grady, William M; Hsu, Li; Hu-Lieskovan, Siwen; Huyghe, Jeroen R; Kim, Yeon Joo; Krystofinski, Paige; Leiserson, Mark D M; Montoya, Dennis J; Nadel, Brian B; Pellegrini, Matteo; Pritchard, Colin C; Puig-Saus, Cristina; Quist, Elleanor H; Raphael, Ben J; Salipante, Stephen J; Shin, Daniel Sanghoon; Shinbrot, Eve; Shirts, Brian; Shukla, Sachet; Stanford, Janet L; Sun, Wei; Tsoi, Jennifer; Upfill-Brown, Alexander; Wheeler, David A; Wu, Catherine J; Yu, Ming; Zaidi, Syed H; Zaretsky, Jesse M; Gabriel, Stacey B; Lander, Eric S; Garraway, Levi A; Hudson, Thomas J; Fuchs, Charles S; Ribas, Antoni.
Afiliação
  • Grasso CS; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center, Los Angeles, California. cgrasso@mednet.ucla.edu.
  • Giannakis M; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Wells DK; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Hamada T; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Mu XJ; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Quist M; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Nowak JA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Nishihara R; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • Qian ZR; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Inamura K; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Morikawa T; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Nosho K; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Abril-Rodriguez G; Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
  • Connolly C; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Escuin-Ordinas H; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Geybels MS; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
  • Grady WM; Department of Oncologic Pathology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Hsu L; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Hu-Lieskovan S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Huyghe JR; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.
  • Kim YJ; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Krystofinski P; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Leiserson MDM; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Montoya DJ; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Nadel BB; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Pellegrini M; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Pritchard CC; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Puig-Saus C; Department of Medicine, University of Washington School of Medicine, Seattle, Washington.
  • Quist EH; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Raphael BJ; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Salipante SJ; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Shin DS; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington.
  • Shinbrot E; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Shirts B; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Shukla S; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Stanford JL; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Sun W; Department of Computer Science and Center for Computational Molecular Biology, Brown University, Providence, Rhode Island.
  • Tsoi J; Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, Los Angeles, California.
  • Upfill-Brown A; Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, Los Angeles, California.
  • Wheeler DA; Department of Molecular, Cell, and Developmental Biology, University of California, Los Angeles, Los Angeles, California.
  • Wu CJ; Department of Laboratory Medicine, University of Washington, Seattle, Washington.
  • Yu M; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Zaidi SH; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Zaretsky JM; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Gabriel SB; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Lander ES; Department of Computer Science and Center for Computational Molecular Biology, Brown University, Providence, Rhode Island.
  • Garraway LA; Department of Laboratory Medicine, University of Washington, Seattle, Washington.
  • Hudson TJ; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles, and the Jonsson Comprehensive Cancer Center, Los Angeles, California.
  • Fuchs CS; Parker Institute for Cancer Immunotherapy, San Francisco, California.
  • Ribas A; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas.
Cancer Discov ; 8(6): 730-749, 2018 06.
Article em En | MEDLINE | ID: mdl-29510987
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Evasão Tumoral Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Evasão Tumoral Limite: Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2018 Tipo de documento: Article